Literature DB >> 3756063

Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid.

J O Miners, N Grgurinovich, A G Whitehead, R A Robson, D J Birkett.   

Abstract

Salicylic acid and acetylsalicylic acid (aspirin) disposition after an oral dose of aspirin, 900 mg (equivalent to 689.7 mg of salicylic acid) was studied in eight males, eight females and eight females receiving oral contraceptive steroids (OCS). Salicylic acid clearance was 61% higher in males compared to the control female group, an effect due largely to enhanced activity of the glycine conjugation pathway (salicyluric acid formation) in males. Salicylic acid clearance was 41% higher in OCS-users compared to the control female group due to increases in both the glycine and glucuronic acid conjugation pathways in the pill users. There was no difference in any salicylic acid disposition parameter between males and OCS-users. Area under the plasma concentration-time curve (AUC) and elimination half-life of aspirin was significantly greater and aspirin plasma hydrolysis rate was significantly lower in both female groups compared to males. There was no difference between OCS-users and the control female group in any of these parameters. Aspirin AUC and elimination half-life were significantly correlated with aspirin plasma hydrolysis rate. These data confirm the importance of hormonal factors in the regulation of drug conjugation reactions in humans and suggest that sex-related differences in salicylic acid and aspirin disposition may be of clinical importance.

Entities:  

Keywords:  Biology; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Demographic Factors; Drugs; Family Planning; Metabolic Effects; Oral Contraceptives; Physiology; Population; Population Characteristics; Research Methodology; Sex Factors; Steroid Metabolic Effects; Treatment

Mesh:

Substances:

Year:  1986        PMID: 3756063      PMCID: PMC1401110          DOI: 10.1111/j.1365-2125.1986.tb05240.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  33 in total

1.  Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis.

Authors:  G G Graham; G D Champion; R O Day; P D Paull
Journal:  Clin Pharmacol Ther       Date:  1977-10       Impact factor: 6.875

2.  Serum aspirin esterase activity in women with habitual aspirin intake.

Authors:  J D Gupta; V Gupta
Journal:  Clin Chim Acta       Date:  1977-12-15       Impact factor: 3.786

3.  The influence of age on the activity of acetylsalicylic acid-esterase and protein-salicylate binding.

Authors:  A Windorfer; W Kuenzer; R Urbanek
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  The incidence of aspirin ingestion in patients with peptic ulcer.

Authors:  J M Duggan; B L Chapman
Journal:  Med J Aust       Date:  1970-04-18       Impact factor: 7.738

5.  Properties and reactions of salicyl-coenzyme A.

Authors:  S L Tishler; P Goldman
Journal:  Biochem Pharmacol       Date:  1970-01       Impact factor: 5.858

6.  Enzymatic conversion of salicylate to salicylurate.

Authors:  W B Forman; E D Davidson; L T Webster
Journal:  Mol Pharmacol       Date:  1971-05       Impact factor: 4.436

7.  Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration.

Authors:  L J Lesko; P K Narang; L Yeager; N R Cutler
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Lorazepam kinetics in the elderly.

Authors:  D J Greenblatt; M D Allen; A Locniskar; J S Harmatz; R I Shader
Journal:  Clin Pharmacol Ther       Date:  1979-07       Impact factor: 6.875

9.  Pharmacokinetics of salicylate elimination in man.

Authors:  G Levy
Journal:  J Pharm Sci       Date:  1965-07       Impact factor: 3.534

Review 10.  Aspirin intolerance--a review.

Authors:  M A Abrishami; J Thomas
Journal:  Ann Allergy       Date:  1977-07
View more
  24 in total

1.  Comparative pharmacokinetics of salicylate in camels, sheep and goats.

Authors:  B H Ali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Apr-Jun       Impact factor: 2.441

2.  Effect of oral contraceptive steroids on the pharmacokinetics of phenprocoumon.

Authors:  H Mönig; C Baese; H T Heidemann; E E Ohnhaus; H M Schulte
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

3.  Aspirin as a COX inhibitor and anti-inflammatory drug in human skeletal muscle.

Authors:  Stephen M Ratchford; Kaleen M Lavin; Ryan K Perkins; Bozena Jemiolo; Scott W Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

4.  Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.

Authors:  L O Eriksson; E Wåhlin-Boll; H Liedholm; P Seideman; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 5.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 6.  Pharmacokinetic drug interactions with oral contraceptives.

Authors:  D J Back; M L Orme
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 7.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

Review 8.  Gender and anti-thrombotic therapy: from biology to clinical implications.

Authors:  Rossella Marcucci; Gabriele Cioni; Betti Giusti; Cinzia Fatini; Lorenza Rossi; Maddalena Pazzi; Rosanna Abbate
Journal:  J Cardiovasc Transl Res       Date:  2014-01-28       Impact factor: 4.132

9.  Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry.

Authors:  N A Dobbs; C J Twelves; H Gillies; C A James; P G Harper; R D Rubens
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 10.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.